IL6 and colitis: Moreover, treating mice with the potent semi-synthetic FXR ligand 6-Ethyl CDCA attenuated the severity of colitis and immune cell activation and the expression of various pro-inflammatory cytokines, such as TNF alpha, IL-1beta, and IL-6 in WT but not in FXR -/- mice [36].